$205.40
-2.37-1.14%
At close: Aug 24, 5:00 PM EST
$205.40
N/A
After Hours: 4:00 PM EST
Axsome Therapeutics Inc Stock News
AXSMNASDAQ
Latest Axsome Therapeutics Stock News | NASDAQ:AXSM | Benzinga
Get the latest news on Axsome Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Axsome Therapeutics performance
Categories: All
Monday, August 17, 2026
Thursday, August 13, 2026
Wednesday, August 12, 2026
Tuesday, August 11, 2026
- Morgan Stanley Maintains Equal-Weight on Axso...PRO
- RBC Capital Maintains Outperform on Axsome Th...PRO
- Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results
- Guggenheim Maintains Buy on Axsome Therapeuti...PRO
- Wells Fargo Maintains Overweight on Axsome Th...PRO
- Target To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday
- Needham Maintains Buy on Axsome Therapeutics,...PRO
Monday, August 10, 2026
Friday, July 31, 2026
Tuesday, July 21, 2026
Wednesday, July 15, 2026
Wednesday, July 08, 2026
Tuesday, July 07, 2026
Friday, June 26, 2026
Wednesday, June 17, 2026
Monday, June 15, 2026
Friday, June 05, 2026
Thursday, June 04, 2026
Wednesday, June 03, 2026
Tuesday, May 26, 2026
Friday, May 08, 2026
Tuesday, May 05, 2026
- Morgan Stanley Maintains Equal-Weight on Axso...PRO
- RBC Capital Maintains Outperform on Axsome Th...PRO
- Wells Fargo Maintains Overweight on Axsome Th...PRO
- Guggenheim Maintains Buy on Axsome Therapeuti...PRO
- Mizuho Maintains Outperform on Axsome Therape...PRO
- Baird Maintains Outperform on Axsome Therapeu...PRO
- HC Wainwright & Co. Maintains Buy on Axsome T...PRO
- Needham Maintains Buy on Axsome Therapeutics,...PRO
Monday, May 04, 2026
- Axsome Therapeutics shares are trading higher...PRO
- Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday
- Axsome Therapeutics Q1 2026 Earnings Call: Complete Transcript
- Strong Drug Sales Lift Axsome Revenue, But Profit Miss Drags Stock
- Earnings Scheduled For May 4, 2026
- HC Wainwright & Co. Maintains Buy on Axsome T...PRO
- Axsome Therapeutics Q1 EPS $(1.26) Misses $(0...PRO
